Chronic fatigue in childhood cancer survivors is associated with lifestyle and psychosocial factors; a DCCSS LATER study

Autor: Penson, A., Walraven, I., Bronkhorst, E., Grootenhuis, M.A., Maurice-Stam, H., de Beijer, I., van der Heiden-van der Loo, M., Tissing, W.J.E., van der Pal, H.J.H., de Vries, A.C.H., Bresters, D., Ronckers, C.M., van den Heuvel-Eibrink, M.M., Neggers, S., Versluys, B.A.B., Louwerens, M., Pluijm, S.M.F., Blijlevens, N., van Dulmen-den Broeder, E., Kremer, L.C.M., Knoop, H., Loonen, J.

Publikováno v: In ESMO Open December 2023 8(6)

Prevalence and determinants of dyslipidemia in 2,338 Dutch childhood cancer survivors: a DCCS-LATER 2 Study.

Autor: Bolier M; Dept. of Internal Medicine, section Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pluimakers VG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Winter DTC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dept. of Biomedical Data Science, section Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.; Mathematical Institute Leiden University, Leiden, The Netherlands., van den Berg SAA; Dept. of Internal Medicine, section Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Dulmen-den Broeder E; Pediatric Oncology, Cancer Center Amsterdam, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Höfer I; Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands., Janssens GO; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dept. of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dept. of Pediatric Oncology, Emma Children's Hospital/Amsterdam UMC, Amsterdam, The Netherlands., Loonen JJ; Dept. of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Louwerens M; Dept. of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands., van der Pal HJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dept. of Pediatric Oncology/Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dept. of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, Netherlands., van der Lely AJ; Dept. of Internal Medicine, section Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., Neggers SJCMM; Dept. of Internal Medicine, section Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.

Risk and Protective Factors of Psychosocial Functioning in Survivors of Childhood Cancer: Results of the DCCSS-LATER Study.

Autor: Maas A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Maurice-Stam H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Feijen EAML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Aa-van Delden AM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Streefkerk N; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Dulmen-den Broeder E; Department of Pediatric Oncology/Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Loonen JJ; Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands.; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., Ronckers C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics Informatics and Epidemiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Neggers S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands., Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands., Versluys BAB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Grootenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Publikováno v: Psycho-oncology [Psychooncology] 2024 Oct; Vol. 33 (10), pp. e9313.

Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE.

Autor: van der Perk MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: m.e.m.vanderperk@prinsesmaximacentrum.nl., Broer L; Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Yasui Y; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Laven JSE; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of pediatric oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Versluys B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Lambalk CB; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Overbeek A; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Loonen JJ; Department of Haematology, Radboud University Medical Center, Nijmegen, the Netherlands., Beerendonk CCM; Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands., Byrne J; Boyne Research Institute, Bettystown, Ireland., Berger C; Department of Paediatric Oncology, University Hospital, Saint-Etienne, France; Lyon University, Jean Monnet University, INSERM, Sainbiose, Saint-Etienne, France., Clemens E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dulmen-den Broeder E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Dirksen U; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany; German Cancer Research Centre, DKTK, Sites Duesseldorf-Essen, Essen, Germany., van der Pal HJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Winther JF; Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark., Ranft A; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany; German Cancer Research Centre, DKTK, Sites Duesseldorf-Essen, Essen, Germany., Fosså SD; Department of Oncology, Oslo University Hospital, Oslo, Norway., Grabow D; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Muraca M; Division of Pediatric Hematology and Oncology, DOPO Clinic, IRCCS Istituto Giannina Gaslini, Via G. Gaslini, Genoa, Italy., Kaiser M; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kepák T; University Hospital Brno, International Clinical Research Center (FNUSA-ICRC), Masaryk University, Brno, Czech Republic., Kruseova J; Department of Pediatric Hematology and Oncology, Motol University Hospital, Prague, Czech Republic., Modan-Moses D; The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel; The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Spix C; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Zolk O; Institute of Clinical Pharmacology, Brandenburg Medical School Theodor Fontane, Immanuel Klinik Rüdersdorf, Neuruppin, Germany., Kaatsch P; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Brooke RJ; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Wang F; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Baedke JL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Uitterlinden AG; Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Bos AME; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Reproductive Medicine, University Medical Center, Utrecht, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ness KK; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Hudson MM; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee; Division of Survivorship, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., van der Kooi ALF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Division of Child Health, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

Publikováno v: Fertility and sterility [Fertil Steril] 2024 Sep; Vol. 122 (3), pp. 514-524. Date of Electronic Publication: 2024 May 09.

Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study.

Autor: Bouwman E; Radboud University Medical Center, Nijmegen, The Netherlands., Penson A; Radboud University Medical Center, Nijmegen, The Netherlands., de Valk M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Oever SR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; PanCare, Bussum, The Netherlands., van Dulmen-den Broeder E; Amsterdam University Medical Center, Amsterdam, The Netherlands., Blijlevens NMA; Radboud University Medical Center, Nijmegen, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.; Utrecht University and Utrecht Medical Center, Utrecht, The Netherlands., van der Heiden-van der Loo M; Dutch Childhood Oncology Group-Late Effects After Childhood Cancer (LATER) Registry, Utrecht, The Netherlands., Michel G; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Groningen, Groningen, The Netherlands., Versluys BAB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Utrecht University and Utrecht Medical Center, Utrecht, The Netherlands.; Amsterdam University Medical Center, Amsterdam, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Loonen JJ; Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Cancer [Cancer] 2024 Aug 15; Vol. 130 (16), pp. 2856-2872. Date of Electronic Publication: 2024 Apr 25.